Synthorx, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.94B

111 transactions

Summary

Synthorx, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $148.0MSales: —18 insiders

Date	Insider	Type	Value
2020-01-23	Joint reporting: RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Shah Rajeev M.	U	$661.3M
2020-01-23	Joint reporting: RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Shah Rajeev M.	U	$661.3M
2020-01-23	Kolchinsky Peter	U	$661.3M
2020-01-23	Lichter Jay	U	$114.4M
2020-01-23	Lichter Jay	U	$30.5M
2020-01-23	Leveque Joseph(Chief Medical Officer)	U	$21.5M
2020-01-23	Milla Marcos(Chief Scientific Officer)	D	$15.3M
2020-01-23	Lichter Jay	U	$10.2M
2020-01-23	Milla Marcos(Chief Scientific Officer)	D	$7.1M
2020-01-23	Milla Marcos(Chief Scientific Officer)	D	$6.0M
2020-01-23	Milla Marcos(Chief Scientific Officer)	U	$4.4M
2020-01-23	CAPPS VICKIE L	D	$4.2M
2020-01-23	Leveque Joseph(Chief Medical Officer)	D	$2.4M
2020-01-23	Kolchinsky Peter	D	$1.7M
2020-01-23	Lichter Jay	D	$1.7M
2020-01-23	Powell Andrew Kenneth William	D	$1.5M
2020-01-23	CAPPS VICKIE L	D	$853K
2020-01-23	Kolchinsky Peter	D	$853K
2020-01-23	Lichter Jay	D	$853K
2020-01-23	Powell Andrew Kenneth William	D	$355K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Synthorx, Inc. — Contributions, Lobbying & Contracts | Poliscope